These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis]. Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599 [No Abstract] [Full Text] [Related]
44. Activated protein C resistance: the most common risk factor for venous thromboembolism. Sheppard DR J Am Board Fam Pract; 2000; 13(2):111-5. PubMed ID: 10764192 [TBL] [Abstract][Full Text] [Related]
46. [Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature]. Bentolila S; Samama MM; Conard J; Horellou MH; Ffrench P Ann Med Interne (Paris); 1995; 146(8):575-80. PubMed ID: 8734083 [TBL] [Abstract][Full Text] [Related]
47. [A new cause of hereditary venous thrombosis: activated protein C resistance]. Trossaërt M; Conard J; Horellou MH; Meyer Samama M Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):438-42. PubMed ID: 8669795 [No Abstract] [Full Text] [Related]
48. Molecular genetics of venous thromboembolism. Dahlbäck B Ann Med; 1995 Apr; 27(2):187-92. PubMed ID: 7632412 [TBL] [Abstract][Full Text] [Related]
50. [Inherited thrombophilia: pathogenesis, clinical and treatment aspects]. Łopaciuk S Pol Arch Med Wewn; 2000 Nov; 104(5):795-803. PubMed ID: 11434093 [No Abstract] [Full Text] [Related]
51. Thrombophilia: some recent advances in understanding. James CM J R Nav Med Serv; 1995; 81(3):203-6. PubMed ID: 8736314 [TBL] [Abstract][Full Text] [Related]
52. The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature. Hoerl HD; Tabares A; Kottke-Marchant K Vasc Med; 1996; 1(4):275-80. PubMed ID: 9552583 [TBL] [Abstract][Full Text] [Related]
53. Activated protein C resistance and pregnancy loss. Dawood F; Farquharson R; Quenby S Hosp Med; 2003 Jan; 64(1):24-7. PubMed ID: 12572331 [TBL] [Abstract][Full Text] [Related]
54. Hereditary and acquired thrombophilia. Part I. Preface. Bick RL Semin Thromb Hemost; 1999; 25(3):251-3. PubMed ID: 10443956 [No Abstract] [Full Text] [Related]
56. [Activated protein C resistance--a recently discovered hereditary thrombophilia]. Moland L; Sandset PM Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002 [TBL] [Abstract][Full Text] [Related]
57. Activated protein C resistance--a major risk factor for thrombosis. Rosén SB; Sturk A Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726 [TBL] [Abstract][Full Text] [Related]
58. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. Dahlbck B J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175 [TBL] [Abstract][Full Text] [Related]
59. Resistance to activated protein C: a major cause of inherited thrombophilia. Jensen R; Ens GE Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621 [TBL] [Abstract][Full Text] [Related]
60. [National evaluation of the diagnosis of activated protein C resistance]. Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]